203
Acknowledgments
The authors thankDrAlanD’Andrea (Harvard Medical School)for
the pMMP-Puro, pMMP-FANCD2, and pMMP-K561R-FANCD2
retroviral vectors,theFanconiAnemia Comprehensive Care Center
(Cincinnati Children’s Hospital Medical Center) for BM samples,
and the VectorCore ofthe Cincinnati Children’s Research Founda-
tion (Cincinnati Children’s Hospital Medical Center) for the
preparationof lentiviruses.
This work was supported in part by National Institutes of Health
(NIH)grants R01HL076712andR01 CA157537.Q.P.is supportedby
aLeukemia and Lymphoma Scholar award. W.D. is supported by a
FanconiAnemiaResearchFundgrantandanNIH T32traininggrant.
Authorship
Contribution: W.D. designed and performed research, analyzed
data, and wrote the manuscript; R.R., K.C.M., and P.M. performed
research and analyzed data; J. Sipple and J. Schick performed
research; P.R.A. and S.M.D. designed research; and Q.P. designed
research, analyzed data, and wrote the manuscript.
Conflict-of-interest disclosure: The authors declare no compet-
ing financial interests.
Correspondence:Qishen Pang,Divisionof Experimental Hema-
tologyand CancerBiology, Cincinnati Children’s Hospital Medical
Center, 3333 Burnet Ave, Cincinnati, OH 45229; e-mail: qishen.
pang@cchmc.org.
References
1. KlaunigJE,Kamendulis LM,HocevarBA. Oxida-
tivestress andoxidativedamageincarcinogen-
esis. ToxicolPathol. 2010;38(1):96-109.
2. WeissJM,GoodeEL, LadigesWC,UlrichCM.
Polymorphic variationinhOGG1andrisk of can-
cer:Areviewof thefunctionalandepidemiologic
literature. MolCarcinog.2005;42(3):127-141.
3. TanakaH,FujitaN,SugimotoR, etal. Hepaticoxida-
tiveDNAdamageisassociatedwithincreasedrisk
forhepatocellularcarcinomainchronichepatitisC.
BrJCancer.2008;98(3):580-586.
4. GottschlingBC, Maronpot RR, Hailey JR, etal.
Theroleof oxidativestressinindiumphosphide-
inducedlungcarcinogenesis inrats. ToxicolSci.
2001;64(1):28-40.
5. MugurumaM, UnamiA,KankiM, etal.Possible
involvement ofoxidativestressinpiperonylbu-
toxideinducedhepatocarcinogenesis inrats.
Toxicology.2007;236(1-2):61-75.
6. Cadet J, DoukiT, RavanatJ.Oxidatively gener-
atedbasedamagetocellularDNA. FreeRadic
BiolMed. 2010;49(1):9-21.
7. MarnettLJ. OxyradicalsandDNAdamage. Carci-
nogenesis. 2000;21(3):361-370.
8. GoodarziAA, JeggoP, LobrichM. Theinfluence
of heterochromatinonDNAdoublestrandbreak
repair:gettingthestrong,silent typetorelax.
DNARepair. 2010;9(12):1273-1282.
9. Shuck SC, ShortEA,TurchiJJ. Eukaryoticnucle-
otideexcisionrepair: fromunderstandingmecha-
nismstoinfluencingbiology. CellRes. 2008;
18(1):64-72.
10. SvilarD,GoellnerEM,AlmeidaKH,SobolRW.
Baseexcisionrepairandlesion-dependent sub-
pathwaysforrepairofoxidativeDNAdamage.
AntioxidRedox Signal. 2011;14(12):2491-507.
11. NeumannCA, KrauseDS,CarmanCV, etal. Es-
sentialrolefortheperoxiredoxinPrdx1inerythro-
cyteantioxidant defenseandtumorsuppression.
Nature.2003;424(6948):561-565.
12. Fruehauf JP,MeyskensFLJr. Reactiveoxygen
species: abreathof lifeordeath?ClinCancer
Res. 2007;13(3):789-794.
13. IshiiT, ItohK, YamamotoM. Rolesof Nrf2inacti-
vationofantioxidantenzymegenes viaantioxi-
dant responsiveelements.Methods Enzymol.
2002;348:182-190.
14. LeeJM,JohnsonJA. Animportant roleof Nrf2-
AREpathwayinthecellulardefensemechanism.
JBiochemMolBiol.2004;37(2):139-143.
15. DuW,AdamZ,RaniR,ZhangX,PangQ. Oxida-
tivestress inFanconianemiahematopoiesisand
diseaseprogression. AntioxidRedox Signal.
2008;10(11):1909-1921.
16. BagbyGC Jr. Genetic basisof Fanconianemia.
CurrOpinHematol. 2003;10(1):68-76.
17. KennedyRD,D’AndreaAD.TheFanconianemia/
BRCApathway:newfacesinthecrowd. Genes
Dev. 2005;19(24):2925-2940.
18. GreenAM, KupferGM.Fanconianemia.Hematol
OncolClinNorthAm.2009;23(2):193-214.
19. DeansAJ,West SC.DNAinterstrandcrosslink
repairandcancer. NatRev Cancer.2011;11(7):
467-480.
20. PangQ,AndreassenPR. Fanconianemiapro-
teinsandendogenous stresses.MutatRes.2009;
668(1-2):42-53.
21. LuT,PanY, KaoSY,et al.Generegulationand
DNAdamageintheageinghumanbrain. Nature.
2004;429(6994):883-891.
22. SpencerVA, SunJM,LiL, DavieJR. Chromatin
immunoprecipitation: atoolforstudyinghistone
acetylationandtranscriptionfactorbinding. Meth-
ods.2003;31(1):67-75.
23. DuW,LiJ, SippleJ,ChenJ, PangQ.Acytoplas-
micFANCA-FANCC complexinteracts andstabi-
lizestheleukemic NPMcprotein. JBiolChem.
2010;285(48):37436-37444.
24. WangX,AndreassenPR, D’AndreaAD.Func-
tional interactionof monoubiquitinatedFANCD2
andBRCA2/FANCD1inchromatin.Mol CellBiol.
2004;24(13):5850-5862.
25. BoglioloM,Cabre´ O, Calle´nE, et al.TheFanconi
anaemiagenomestability andtumor suppressor
network. Mutagenesis.2002;17(6):529-538.
26. Montes deOcaR,AndreassenPR, MargossianSP,
et al.Regulatedinteractionof theFanconiane-
miaprotein, FANCD2, withchromatin. Blood.
2005;105(3):1003-1009.
27. Athas WF,HedayatiMA,MatanoskiGM,FarmerER,
GrossmanL.Developmentandfieldtestvalida-
tionofanassay forDNArepairincirculatinghu-
manlymphocytes.Cancer Res.1991;51(21):
5786-5793.
28. Muchardt C, Yaniv M. WhentheSWI/SNF com-
plex remodels thecellcycle.Oncogene. 2001;
20(24):3067-3075.
29. KadamS,EmersonBM.Transcriptionalspecificityof
humanSWI/SNFBRG1andBRMchromatinremod-
elingcomplexes.MolCell.2003;11(2):377-389.
30. OtsukiT,FurukawaY,IkedaK,et al. Fanconi
anemiaprotein,FANCA, associates withBRG1, a
component ofthehumanSWI/SNFcomplex.
HumMolGenet.2001;10(23):2651-2660.
31. ForsbergEC,Downs KM,ChristensenHM, Im H,
NuzziPA, BresnickEH. Developmentallydy-
namic histoneacetylationpatternofatissue-
specific chromatindomain. Proc NatlAcadSci
US A. 2000;97(26):14494-14499.
32. JenuweinT,Allis CD. Translatingthehistone
code. Science.2001;293(5532):1074-1080.
33. ThomasS,GreenA, Sturm NR, CampbellDA,
MylerPJ. Histoneacetylationmarkorigins of
polycistronictranscriptioninLeishmaniamajor.
BMCGenomics. 2009;10:152-166.
34. GhoshR,MitchellDL.Effect of oxidativeDNA
damageinpromoterelementsontranscription
factorbinding. NucleicAcids Res. 1999;27(15):
3213-3218.
35. Park SJ,CicconeSL, BeckBD, etal. Oxidative
stress/damageinduces multimerizationandinter-
actionofFanconianemiaproteins.J BiolChem.
2004;279(29):30053-30059.
36. CummingRC,LiuJM,YoussoufianH,BuchwaldM.
Suppressionofapoptosis inhematopoietic factor-
dependent progenitorcelllinesbyexpressionof
theFAC gene. Blood.1996;88(12):4558-4567.
37. Kruyt FA,HoshinoT,LiuJM,JosephP, JaiswalAK,
YoussoufianH.Abnormalmicrosomaldetoxifica-
tionimplicatedinFanconianemiagroupCbyin-
teractionoftheFAC proteinwithNADPHcyto-
chromeP450reductase. Blood.1998;92(9):3050-
3056.
38. HadjurS, UngK,WadsworthL, et al.Defective
hematopoiesis andhepaticsteatosis inmicewith
combineddeficiencies ofthegenesencoding
FanccandCu/Znsuperoxidedismutase.Blood.
2001;98(4):1003-1011.
39. SaadatzadehMR,Bijangi-VishehsaraeiK,HongP,
BergmannH, HanelineLS.Oxidanthypersensi-
tivityof Fanconi anemiatypeC-deficientcells is
dependent onaredox-regulatedapoptotic path-
way. JBiolChem. 2004;279(16):16805-16812.
40. FutakiM,IgarashiT, WatanabeS, et al.The
FANCG Fanconianemiaproteininteracts with
CYP2E1:possibleroleinprotectionagainstoxi-
dativeDNAdamage. Carcinogenesis.2002;
23(1):67-72.
41. Mukhopadhyay SS, LeungKS,HicksMJ,
Hastings PJ,YoussoufianH, PlonSE. Defective
mitochondrialperoxiredoxin-3results insensitiv-
itytooxidativestress inFanconianemiaJCell
Biol. 2006;175(2):225-235.
42. Li J,DuW, MaynardS,AndreassenPR, PangQ.
Oxidativestress-specificinteractionbetween
FANCD2andFOXO3a.Blood.2010;115(8):1545-
1548.
43. ZhangJ,OhtaT, MaruyamaA, etal. BRG1inter-
acts withNrf2toselectivelymediateHO-1induc-
tioninresponsetooxidativestress. MolCellBiol.
2006;26(21):7942-7952.
44. HuangM,QianF, HuY,AngC, LiZ, WenZ.
Chromatin-remodelingfactorBRG1selectively
activatesasubset ofinterferon-alpha-inducible
genes. NatCell Biol. 2002;4(10):774-781.
45. MenoniH, GasparuttoD,HamicheA, etal.ATP-
dependentchromatinremodelingisrequiredforbase
excisionrepairinconventionalbutnotinvariantH2A.
MolCellBiol.2007;27(17):5949-5956.
46. Lukas J, LukasC, BartekJ. Morethanjust afo-
cus: thechromatinresponsetoDNAdamageand
itsroleingenomeintegrity maintenance.Nat Cell
Biol. 2011;13(10):1161-1169.
FAPATHWAYPROTECTSANTIOXIDANTDEFENSE GENES
4151
BLOOD,3 MAY 2012
VOLUME119, NUMBER18